Screener
Maze Therapeutics MAZE Total Current Liabilities
Total Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Maze Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.
The source filing: Maze Therapeutics’s 10-Q, filed August 11, 2026.
- Filed
- Aug 11, 2026, 4:48 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-344903
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Accounts payable | $2,212 | $1,794 |
| Accrued expenses and other current liabilities | 15,866 | 15,967 |
| Operating lease liabilities, current | 4,883 | 4,795 |
| Total current liabilities | 22,961 | 22,556 |
| Operating lease liabilities, net of current portion | 16,580 | 18,511 |
| Term loan, non-current | 38,960 | — |
| Other liabilities, non-current | — | 1,094 |
| Total liabilities | 78,501 | 42,161 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Maze Therapeutics's total current liabilities?
- Maze Therapeutics (MAZE) reported total current liabilities of $22.96M in Q2 2026.
- How has Maze Therapeutics's total current liabilities changed year-over-year?
- Maze Therapeutics's total current liabilities increased by 15.4% year-over-year, from $19.9M to $22.96M.
- What does total current liabilities mean?
- The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.
Ask your AI about Maze Therapeutics's total current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude